Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in Endometrial Cancer
NCT02767362Phase 1Completed
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Nov 2015
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of atorvastatin in endometrial cancer (EC), sponsored by UNC Lineberger Comprehensive Cancer Center. Primary endpoint: Absolute difference score at 2 years. Started Nov 2015; status: completed.
02
Drugs
atorvastatin
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT02767362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02767362.